Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silicone breast implant research on local effects should be "top priority" -- FDA study authors.

This article was originally published in The Gray Sheet

Executive Summary

SILICONE BREAST IMPLANT RUPTURE IMPROVED TEST METHODS NEEDED to provide "more information on rates of rupture in general and the influence of rupture on other local and systemic complications," FDA scientist Barbara Silverman, MD, et al. say in a literature review appearing in the April 15 issue of Annals of Internal Medicine. The article says that information on local effects of the implants, such as rupture, capsular contracture and silicone migration, should be "a top priority on the research agenda."
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005838

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel